360 Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Sell
266
-22
-8% -$22.5K 0.08% 63
2026
Q1
$265K Buy
288
+3
+1% +$3.04K 0.08% 62
2025
Q4
$306K Buy
285
+6
+2% +$5.74K 0.09% 61
2025
Q3
$213K Buy
+279
New +$208K 0.07% 79

Other funds holding LLY

360 Financial's LLY Position: Q2 2026 in Review

360 Financial reduced its Eli Lilly (LLY) stake by 7.6% in Q2 2026, selling an estimated $22.5K and leaving 266 shares worth $319K. The position accounts for 0.08% of the portfolio, ranked #63.

360 Financial first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • 360 Financial held 266 shares of Eli Lilly worth $319K as of Q2 2026.
  • 360 Financial sold 22 Eli Lilly shares in Q2 2026, an estimated $22.5K.
  • Eli Lilly made up 0.08% of 360 Financial's portfolio in Q2 2026, its #63 holding.
  • 360 Financial first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on 360 Financial's 13F filing for Q2 2026, filed 11 Aug 2026.